Recruiting
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
NCT05854498
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States